MarcSabatineMD

PubMed

• Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
  Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian L Claggett, Robert A Fletcher, Willi...> ;Circulation. 2024 Apr 7
• Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF.
  Toru Kondo, Ulrik M Mogensen, Atefeh Talebi, Samvel B Gasparyan, Ross T Campbell, Kieran F Docherty, Rudolf A de Boer, Silvio E Inzucchi, Lars Køber, Mikhail N Kosibor...> ;Journal of the American College of Cardiology. 2024 Mar 25
• Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER.
  Jawad H Butt, Pardeep S Jhund, Kieran F Docherty, Brian L Claggett, Muthiah Vaduganathan, Erasmus Bachus, Adrian F Hernandez, Carolyn S P Lam, Silvio E Inzucchi, Felip...> ;JACC. Heart Failure. 2024 Mar 22
• Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
  Alexander Peikert, Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac, Alberto Foà, Akshay S Desai, Pardeep S Jhund, Jaclyn Carberry, Carolyn S P Lam, Mikhail N Kosib...> ;European Journal of Heart Failure. 2024 Mar 15
• Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.
  Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, Sabina A Murphy, Xinhui Ran, Candace R Bramson, Madelyn Curto, Vesper Ramos, Alexandra Jevne, Julia F Kuder, Subodh ...> ;European Journal of Preventive Cardiology. 2024 Mar 14
• Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis ...
  Prakriti Gaba, Joseph F Sabik, Sabina A Murphy, Andrea Bellavia, Patrick T O'Gara, Peter K Smith, Patrick W Serruys, A Pieter Kappetein, Seung-Jung Park, Duk-Woo Park,...> ;Circulation. 2024 Mar 11
• Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data Fro...
  Ankeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail N Kosibo...> ;Journal of the American Heart Association. 2024 Mar 5
• Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
  Jawad H Butt, Karola Jering, Rudolf A DE Boer, Brian L Claggett, Akshay S Desai, Adrian F Hernandez, Silvio E Inzucchi, Pardeep S Jhund, Lars Køber, Mikhail N Kosiboro...> ;Journal of Cardiac Failure. 2024 Mar 1
• Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis.
  Aeron M Small, Giorgio E M Melloni, Frederick K Kamanu, Brian A Bergmark, Marc P Bonaca, Michelle L O'Donoghue, Robert P Giugliano, Benjamin M Scirica, Deepak Bhatt, E...> ;JAMA Cardiology. 2024 Apr 1
• Deficiency of lncRNA MERRICAL abrogates macrophage chemotaxis and diabetes-associated atherosclerosis.
  Jingshu Chen, Anurag Jamaiyar, Winona Wu, Yi Hu, Rulin Zhuang, Grasiele Sausen, Henry S Cheng, Camila de Oliveira Vaz, Daniel Pérez-Cremades, Aspasia Tzani, Michael G ...> ;Cell Reports. 2024 Mar 26
• Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
  Aeron M Small, Ashley Pournamdari, Giorgio E M Melloni, Benjamin M Scirica, Deepak L Bhatt, Itamar Raz, Eugene Braunwald, Robert P Giugliano, Marc S Sabatine, Gina M P...> ;JAMA Cardiology. 2024 Apr 1
• 1 citations
  Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease.
  O'Donoghue, M., De Ferrari, G., Ferreira, J., Ran, X., Im, K., López, J., Elliott-Davey, M., Wang, B., Monsalvo, M., Atar, D., Keech, A., McClintick, D., Giugliano, R....> ;Journal of the American College of Cardiology. 2024 Feb 13
• 2 citations
  Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins.
  Melloni, G., Murphy, S., Morze, J., Kamanu, F., Marston, N., Ellinor, P., Ruff, C., Sabatine, M.> ;Journal of the American College of Cardiology. 2024 Jan 23
• 1 citations
  Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.
  Ruzza, A., Murphy, S., De Ferrari, G., Diaz, R., Leiter, L., Elliott-Davey, M., Wang, H., Bhatia, A., Bohula, E., Marston, N., Giugliano, R., Sabatine, M.> ;American Heart Journal. 2024 Mar 1
• 1 citations
  Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61.
  Siddharth M Patel, David A Morrow, Andrea Bellavia, David D Berg, Deepak L Bhatt, Petr Jarolim, Lawrence A Leiter, Darren K McGuire, Itamar Raz, P Gabriel Steg, John P...> ;European Journal of Heart Failure. 2024 Feb 1
• 1 citations
  Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
  Zimerman, A., Wiviott, S., Park, J., Murphy, S., Ran, X., Curto, M., Ramos, V., Jevne, A., Kuder, J., Verma, S., Wojakowski, W., Terra, S., Bergmark, B., Marston, N., ...> ;Journal of Clinical Lipidology. 2023 Dec 10
• 1 citations
  Encased in Peril.
  Gurleen Kaur, Marc S Sabatine, Inga-Marie Schaefer, Yee-Ping Sun, Joseph Loscalzo> ;The New England Journal of Medicine. 2023 Nov 2
• 1 citations
  Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 Trial.
  Palazzolo, M., Steg, P., Storey, R., O'Donoghue, M., Patel, S., Bonaca, M., Morrow, D., Jarolim, P., Bhatt, D., Sabatine, M.> ;JACC. Advances. 2023 Nov 1
• Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials.
  Kondo, T., Gasparyan, S., Jhund, P., Bengtsson, O., Claggett, B., de Boer, R., Hernandez, A., Inzucchi, S., Kosiborod, M., Køber, L., Lam, C., Langkilde, A., Martinez,...> ;NEJM Evidence. 2023 Nov 1
• Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER.
  Toru Kondo, Jawad H Butt, James P Curtain, Pardeep S Jhund, Kieran F Docherty, Brian L Claggett, Muthiah Vaduganathan, Erasmus Bachus, Adrian F Hernandez, Carolyn S P ...> ;Circulation. Heart Failure. 2023 Dec 1
• 3 citations
  Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.
  Safia Chatur, Muthiah Vaduganathan, Brian L Claggett, Finnian R Mc Causland, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, Adrian F Hernandez, Silvio E Inzucchi, ...> ;Journal of the American College of Cardiology. 2023 Nov 7
• 5 citations
  Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
  Helgason, H., Eiriksdottir, T., Ulfarsson, M., Choudhary, A., Lund, S., Ivarsdottir, E., Hjorleifsson Eldjarn, G., Einarsson, G., Ferkingstad, E., Moore, K., Honarpour...> ;JAMA. 2023 Aug 22
• 4 citations
  Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.
  Filipe A Moura, David D Berg, Andrea Bellavia, Jamie P Dwyer, Ofri Mosenzon, Benjamin M Scirica, Stephen D Wiviott, Deepak L Bhatt, Itamar Raz, Mark W Feinberg, Eugene...> ;Diabetes Care. 2023 Oct 1
• 2 citations
  Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
  Toru Kondo, Xiaowen Wang, Mingming Yang, Pardeep S Jhund, Brian L Claggett, Muthiah Vaduganathan, Adrian F Hernandez, Carolyn S P Lam, Silvio E Inzucchi, Felipe A Mart...> ;Journal of the American College of Cardiology. 2023 Sep 5
• 5 citations
  Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
  Kieran F Docherty, Kirsty McDowell, Paul Welsh, Joanna Osmanska, Inder Anand, Rudolf A de Boer, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Eileen O'Meara, Pio...> ;Journal of the American College of Cardiology. 2023 Jul 11
• Join now to see all

Journal Articles

• Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients with Heart Failure with Reduced Ejection Fraction  
  Mikhail N Kosiborod, Marc S Sabatine, JAMA Cardiology
• Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction with Statins, Ezetimibe, and PCSK9 Inhibition  
  Robert P Giugliano, Marc S Sabatine, JAMA Cardiology
• PCSK9 Inhibition—A Tale of 2 Potential Treatment Opportunities—Reply  
  Brian A Bergmark, Marc S Sabatine, JAMA Cardiology
• Association of Hospital-Level Differences in Care with Outcomes Among Patients with Acute ST-Segment Elevation Myocardial Infarction in China  
  Xuan Zhang, Hui Sun, Marc S Sabatine, Stephen D Wiviott, JAMA Network Open
• Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin Therapy  
  Prakash Deedwania, Narimon Honarpour, Marc S Sabatine, Robert P Giugliano, JAMA Cardiology
• Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines  
  Nicholas A Marston, Marc P Bonaca, Petr Jarolim, Deepak L Bhatt, Stephen D Wiviott, Eugene Braunwald, Marc S Sabatine, JAMA Cardiology
• Efficacy of Evolocumab on Cardiovascular Outcomes in Patients with Recent Myocardial Infarction  
  Christopher E Kurtz, Narimon Honarpour, Marc S Sabatine, Robert P Giugliano, JAMA Cardiology
• Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients with Heart Failure with and Without Diabetes  
  Akshay S Desai, Mikhail N Kosiborod, Marc S Sabatine, JAMA
• Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes  
  Stephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
• PCSK9 Inhibitors: Clinical Evidence and Implementation  
  Marc Sabatine, MD, Nature
• Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
  Erin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
• Join now to see all

Lectures

• PCSK9 Inhibitors: What We Know What We Don't Know and Where are We Going? 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019